IL139575A0 - Il-6 antagonist peptides and pharmaceutical compositions containing them - Google Patents

Il-6 antagonist peptides and pharmaceutical compositions containing them

Info

Publication number
IL139575A0
IL139575A0 IL13957599A IL13957599A IL139575A0 IL 139575 A0 IL139575 A0 IL 139575A0 IL 13957599 A IL13957599 A IL 13957599A IL 13957599 A IL13957599 A IL 13957599A IL 139575 A0 IL139575 A0 IL 139575A0
Authority
IL
Israel
Prior art keywords
seq
pharmaceutical compositions
antagonist peptides
compositions containing
present
Prior art date
Application number
IL13957599A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL139575A0 publication Critical patent/IL139575A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5412IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13957599A 1998-05-18 1999-05-18 Il-6 antagonist peptides and pharmaceutical compositions containing them IL139575A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98108997A EP0972780A1 (en) 1998-05-18 1998-05-18 Il-6 antagonist peptides
PCT/EP1999/003421 WO1999060013A2 (en) 1998-05-18 1999-05-18 Il-6 antagonist peptides

Publications (1)

Publication Number Publication Date
IL139575A0 true IL139575A0 (en) 2002-02-10

Family

ID=8231951

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13957599A IL139575A0 (en) 1998-05-18 1999-05-18 Il-6 antagonist peptides and pharmaceutical compositions containing them
IL139575A IL139575A (en) 1998-05-18 2000-11-09 Il-6 antagonist peptides and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139575A IL139575A (en) 1998-05-18 2000-11-09 Il-6 antagonist peptides and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (2) US6599875B1 (enExample)
EP (2) EP0972780A1 (enExample)
JP (1) JP4468578B2 (enExample)
AT (1) ATE347563T1 (enExample)
AU (1) AU749616B2 (enExample)
CA (2) CA2332817C (enExample)
CY (1) CY1105865T1 (enExample)
DE (1) DE69934308T2 (enExample)
DK (1) DK1078001T3 (enExample)
ES (1) ES2273492T3 (enExample)
IL (2) IL139575A0 (enExample)
PT (1) PT1078001E (enExample)
SI (1) SI1078001T1 (enExample)
WO (1) WO1999060013A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0972780A1 (en) * 1998-05-18 2000-01-19 Applied Research Systems ARS Holding N.V. Il-6 antagonist peptides
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
ME00238B (me) 1998-10-23 2011-02-10 Kirin Amgen Inc Mimičko vezivanje dimernog trombopoitetinskog peptida za mp1 receptor sa trombopoietičkom aktivnošću
MX2007000216A (es) 2004-07-08 2007-03-15 Amgen Inc Peptidos terapeuticos.
US20070036788A1 (en) * 2004-09-22 2007-02-15 Ahmed Sheriff Use of a compound for reducing the biological effectiveness of il-6
WO2006036834A2 (en) 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
CN101495146B (zh) 2006-04-07 2012-10-17 国立大学法人大阪大学 肌肉再生促进剂
JO3324B1 (ar) 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
ES2564392T3 (es) 2007-01-23 2016-03-22 Shinshu University Inhibidores de IL-6 para el tratamiento de rechazo crónico
JP5544290B2 (ja) 2008-06-05 2014-07-09 独立行政法人国立がん研究センター 神経浸潤抑制剤
WO2010065077A2 (en) 2008-11-25 2010-06-10 Alder Biopharmaceuticals, Inc. Antagonists of il-6 to prevent or treat thrombosis
EP4115906A1 (en) 2010-05-28 2023-01-11 Chugai Seiyaku Kabushiki Kaisha Antitumor t cell response enhancer
AU2011332817A1 (en) 2010-11-23 2013-06-13 Alder Biopharmaceuticals, Inc. Anti-IL-6 antibodies for the treatment of anemia
RS60050B1 (sr) 2011-01-18 2020-04-30 Bioniz Llc Kompozicije za modulaciju aktivnosti gama-c-citokina
WO2015089217A2 (en) 2013-12-10 2015-06-18 Bionz, Llc Methods of developing selective peptide antagonists
WO2013063229A1 (en) 2011-10-25 2013-05-02 The Regents Of The University Of Michigan Her2 targeting agent treatment in non-her2-amplified cancers having her2 expressing cancer stem cells
CN103923182A (zh) * 2014-01-17 2014-07-16 南通诚信氨基酸有限公司 白介素-6多肽抑制剂及其应用
KR102654684B1 (ko) 2015-10-09 2024-04-04 바이오니즈 테라퓨틱스, 아이엔씨. 감마-c-사이토카인 활성의 조정
WO2018203545A1 (ja) 2017-05-02 2018-11-08 国立研究開発法人国立精神・神経医療研究センター Il-6及び好中球の関連する疾患の治療効果の予測及び判定方法
EP3698808B1 (en) 2017-10-20 2025-01-01 Hyogo College Of Medicine Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
US20220177978A1 (en) 2019-04-02 2022-06-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions
WO2020227019A1 (en) 2019-05-03 2020-11-12 Bioniz, Llc Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders
CN116003530B (zh) * 2022-12-27 2023-12-15 西湖大学 一种针对白细胞介素-6的d-蛋白抑制剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4420782C1 (de) * 1994-06-15 1995-08-17 Fluegge Ulf Ingo Prof Dr DNA-Sequenz, kodierend einen 2-Oxoglutarat/Malat-Translokator, Plasmide, Bakterien, Hefen und Pflanzen enthaltend diesen Transporter
ATE217344T1 (de) * 1994-09-21 2002-05-15 Cytogen Corp Antigen bindende peptide (abtides) aus peptidbibliotheken
WO1996023899A1 (en) * 1995-02-01 1996-08-08 University Of Massachusetts Medical Center Methods of selecting a random peptide that binds to a target protein
AU715125B2 (en) * 1995-05-11 2000-01-20 Merck Serono Sa IL-6 activity inhibitor
WO1997004101A2 (de) * 1995-07-17 1997-02-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Enzym geeignet zur oxidation von cyclitolen und ihren derivaten
AU709585B2 (en) * 1995-09-28 1999-09-02 Yeda Research And Development Co. Ltd. Synthetic peptides that inhibit IL-6 activity
AU3193097A (en) * 1996-06-20 1998-01-07 Koster, Henk W. Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
EP0972780A1 (en) * 1998-05-18 2000-01-19 Applied Research Systems ARS Holding N.V. Il-6 antagonist peptides

Also Published As

Publication number Publication date
IL139575A (en) 2008-03-20
CA2690399C (en) 2015-01-20
EP1078001B1 (en) 2006-12-06
US6599875B1 (en) 2003-07-29
DE69934308D1 (de) 2007-01-18
US20030186876A1 (en) 2003-10-02
CA2332817A1 (en) 1999-11-25
EP0972780A1 (en) 2000-01-19
ATE347563T1 (de) 2006-12-15
AU749616B2 (en) 2002-06-27
WO1999060013A2 (en) 1999-11-25
DE69934308T2 (de) 2007-03-29
EP1078001A2 (en) 2001-02-28
SI1078001T1 (sl) 2007-04-30
CA2690399A1 (en) 1999-11-25
CA2332817C (en) 2010-08-31
ES2273492T3 (es) 2007-05-01
US6838433B2 (en) 2005-01-04
WO1999060013A3 (en) 2000-03-09
JP2002527354A (ja) 2002-08-27
CY1105865T1 (el) 2011-02-02
PT1078001E (pt) 2007-01-31
AU4362799A (en) 1999-12-06
DK1078001T3 (da) 2007-02-19
JP4468578B2 (ja) 2010-05-26

Similar Documents

Publication Publication Date Title
IL139575A0 (en) Il-6 antagonist peptides and pharmaceutical compositions containing them
BG98793A (bg) Нови производни на аминокиселините,методи за тяхното получаване и фармацевтични състави,съдържащи тези съединения
IL104716A (en) 7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino| octahydro-6-pyrido £2, 1-a| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
EP1093372A4 (en) CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF INHIBITING PEPTIDE RELEASE $ g (b) -AMYLOID AND / OR ITS SYNTHESIS USING THE SAME
IL123164A (en) Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them
MX9708780A (es) Nuevos heterociclos como inhibidores de la adhesion de leucocitos y antagonistas de vla-4.
DE69912952D1 (en) Cyclosporine
FI954609A0 (fi) 1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
ES8800943A1 (es) Un procedimiento para preparar compuestos imidazoheterociclicos
AU559914B2 (en) Peptide compounds
BG104630A (en) Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
ES2110115T3 (es) Inhibidores de la agregacion de plaquetas.
PL350891A1 (en) Substituted 1,4-dichlorindene[1,2-c]pyrazoles as inhibitors of tyrosine kinase
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
EP0952159A3 (en) Use of somatostatin derivatives and/or of phenylhydrazone derivatives as antinflammatory or analgetic agents
DK0804418T3 (da) Platelataggregationshæmmere
EP0309971A3 (en) New spergualin-related compound and pharmaceutical composition
EP0817643A4 (en) SUBSTANCES AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
NO974537D0 (no) Plateaggregeringsinhibitorer inneholdende C-terminale aminergiske sidekjedeaminosyrerester
WO1999043701A3 (en) Peptides for inhibition of apoptosis and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed